Immunogenicity Study of a Plasma-Derived Heat-Inactivated Hepatitis-B Vaccine in Newborn Babies: A Randomised Dose-Response Study
β Scribed by Ip, Henrietta M. H. ;Wong, Vivian C. W. ;Reesink, Henk W. ;Lelie, P. Nico ;Yeung, C. Y. ;Ma, H. K.
- Book ID
- 119844674
- Publisher
- Wiley (Blackwell Publishing)
- Year
- 2010
- Tongue
- English
- Weight
- 409 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0389-2328
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Six hundred and fifty New Zealand children from 2-12 years of age were vaccinated three times with 2 mcg intramuscular (IM) doses of Merck Sharp and Dohme plasma-derived hepatitis B vaccine (H-B-Vax), at 0, 1, and 6 months, and tested 2-3 months later for antibody to hepatitis B surface antigen (ant
## Abstract One hundred and one of 255 recipients of a plasmaβderived hepatitis B vaccine were evaluated in 1990, 9 years after the first vaccine dose in a study in Zambia to evaluate the efficacy of one, two, or three doses. In 1983, 2 years after the first vaccine dose, antibody to the hepatitis